Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

148
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
148
Hazard Ratio01:12

Hazard Ratio

166
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
166
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

4.5K
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
4.5K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

38
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rejecting False Claims from Markov Simulations in Alzheimer's Disease.

Innovations in pharmacy·2024
Same author

Post-Menopausal Quality of Life Claims: Overlooking the Requirements of Normal Science and Fundamental Measurement in ICER'S Cost-Effectiveness Assessment of Fezolinetant for Moderate to Severe Vasomotor Symptoms.

Innovations in pharmacy·2023
Same author

After The QALY: Training for a New Start Paradigm in Health Technology Assessment.

Innovations in pharmacy·2023
Same author

Concerns with Patient Reported Outcome Measurement and Value Claims for Therapy Response: The Case of Mavacamten and Symptomatic Hypertrophic Cardiomyopathy (SHCM).

Innovations in pharmacy·2023
Same author

Mapping Impossible Utilities: The ICER Report on Tezepelumab for Severe Asthma.

Innovations in pharmacy·2023
Same author

Formulary Submissions: Value Claims, Protocols and Outcomes Based Contracting in Rare Disease.

Innovations in pharmacy·2023
Same journal

Academic conference posters: A systematic review.

Innovations in pharmacy·2026
Same journal

Evaluation of burnout among pharmacy technicians in South Dakota.

Innovations in pharmacy·2026
Same journal

Africa's vaccines manufacturing revolution: Lessons from COVID-19, ongoing efforts, and challenges to overcome.

Innovations in pharmacy·2026
Same journal

Pharmacist roles across the space mission pathway.

Innovations in pharmacy·2026
Same journal

Allocation and prioritization of hospital pharmacist clinical services in British Columbia.

Innovations in pharmacy·2026
Same journal

Clinical pharmacogenetics: A feasibility study of pharmacy students using a clinical decision support system during their didactic training.

Innovations in pharmacy·2026
See all related articles

Related Experiment Video

Updated: Jul 26, 2025

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

435

Rasch Measurement and Patient Reported Value Claims: A Primer for Hemophilia.

Paul C Langley1

  • 1College of Pharmacy, University of Minnesota, Minneapolis, MN.

Innovations in Pharmacy
|June 12, 2023
PubMed
Summary
This summary is machine-generated.

Rasch Measurement Theory (RMT) offers a robust method for assessing patient-centric therapy response in hemophilia, moving beyond ordinal data to precise interval measurements for improved clinical value claims.

Keywords:
ICHOMRasch measurementfalse outcome claimshemophilia

More Related Videos

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

6.3K
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.0K

Related Experiment Videos

Last Updated: Jul 26, 2025

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

435
Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

6.3K
Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

19.0K

Area of Science:

  • Medical Measurement
  • Clinical Assessment
  • Patient-Reported Outcomes

Background:

  • Current methods for assessing hemophilia treatment response have limitations.
  • There is a need for more precise measurement of patient-centric therapy outcomes.

Purpose of the Study:

  • To propose Rasch Measurement Theory (RMT) as an innovative assessment method for hemophilia A and B.
  • To highlight limitations in current hemophilia response assessment methods.
  • To advocate for adopting RMT standards in hemophilia research and instrument development.

Main Methods:

  • The commentary proposes the application of Rasch Measurement Theory (RMT).
  • RMT facilitates the transition from ordinal observations to interval measurements.
  • Focus on polytomous instruments and their sub-domains for RMT approximation.

Main Results:

  • RMT provides a framework for objective measurement of clinical value and patient-reported outcomes.
  • RMT supports claims related to drug utilization and medical resource allocation.
  • Identifies core claims that meet required measurement standards for hemophilia response.

Conclusions:

  • Rasch Measurement Theory (RMT) is essential for advancing hemophilia research and patient care.
  • Implementing RMT will enhance the validity and reliability of patient-reported outcomes.
  • A new standard for hemophilia response assessment is proposed, utilizing RMT principles.